Content:

• Which Liquid Melatonin is beneficial and which are harmful? What fat is good for health?
• Melatonin Depression alternating menu

Melatonin – Wikipedia

^ “Melatonin – Drugs.com”. Drugs.com. Retrieved 12 October 2018.

^ “Melatonin”. Sleepdex. Retrieved August 17, 2011.

^ a b c d e f g Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL (August 2017). “Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders” (PDF). Sleep Med Rev. 34: 10–22. doi: 10.1016 / j.smrv.2016.06.005. PMID 28648359.

^ Faraone, Stephen V. (2014). ADHD: Non-Pharmacologic Interventions, E-Book. Elsevier Health Sciences. p. 888. ISBN 9780323326025.

^ a b c d e f g Matheson, E; Hainer, BL (July 1, 2017). “Insomnia: Pharmacologic Therapy”. American Family Physician. 96 (1): 29–35. PMID 28671376.

^ a b c d e f British national formulary: BNF 76 (76 ed.). Pharmaceutical Press. 2018. pp. 482–483. ISBN 9780857113382.

^ a b c Brasure M, MacDonald R, Fuchs E, Olson CM, Carlyle M, Diem S, Koffel E, Khawaja IS, Ouellette J, Butler M, Kane RL, Wilt TJ (2015). “Management of Insomnia Disorder [Internet]”. AHRQ Comparative Effectiveness Reviews. 15 (16): EHC027 – EF. PMID 26844312. Evidence for benzodiazepine hypnotics,

^ a b c d e f “Melatonin: Side Effects, Uses, Dosage (Kids / Adults)”. Drugs.com. Retrieved January 9, 2019.

^ a b “Summary Safety Review – MELATONIN (N-acetyl-5-methoxytryptamine) – Review of the Melatonin in Children and Adolescents”. Government of Canada. Health Canada. 10 December 2015. Retrieved 9 January 2019.

^ a b “Melatonin- Oral”. Government of Canada. Health Canada. 28 August 2018. Retrieved 9 January 2019.

^ a b c Altun A, Ugur-Altun B (May 2007). “Melatonin: therapeutic and clinical utilization”. Int. J. Clin. Pract. 61 (5): 835–45. doi: 10.1111 / j.1742-1241.2006.01191.x. PMID 17298593.

^ Boutin JA, Audinot V, Ferry G, Delagrange P (August 2005). “Molecular tools to study melatonin pathways and actions.” Trends Pharmacol. Sci. 26 (8): 412–19. doi: 10.1016 / j.tips 2005.06.006. PMID 15992934.

^ Hardeland R (July 2005). “Antioxidative protection by melatonin: multiplicity of mechanisms from detoxification to radical avoidance”. Endocrine. 27 (2): 119–30. doi: 10.1385 / ENDO: 27: 2: 119. PMID 16217125.

^ Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S (June 2001). “Free radical-mediated molecular damage. Mechanisms for the protective action of melatonin in the central nervous system.” Ann. N. Y. Acad. Sci. 939 (1): 200–15. Bibcode: 2001NYASA.939..200R. doi: 10.1111 / j.1749-6632.2001.tb03627.x. PMID 11462772.

^ Tan DX, Hardeland R, Manchester LC, Korkmaz A, Ma S, Rosales-Corral S, Reiter RJ (2012). “Functional roles of melatonin plants and plants and nutritional and agricultural science”. Journal of Experimental Botany. 63 (2): 577–97. doi: 10.1093 / jxb / err256. PMID 22016420.

^ “Australian Public Assessment Report for Melatonin” (PDF). www.tga.gov.au. The Australian Government Department of Health and Aging Therapeutic Goods Administration. January 2011. pp. 2, 4. Retrieved January 9, 2019. Monotherapy for patients at home.

^ McCarter SJ, et al. (March 2013). “Treatment Outcomes in REM Sleep Behavior Disorder”. Sleep Medicine (Review). 14 (3): 237–242. doi: 10.1016 / j.sleep.2012/09/09. PMC 3617579. PMID 23352028.

^ McKeith IG, Boeve BF, Dickson DW, et al. (July 2017). “DLB Consortium” Diagnosis and management of dementia bodies with the Lewy bodies: Neurology (Review). 89 (1): 88–100. doi: 10.1212 / WNL.0000000000004058. PMC 5496518. PMID 28592453.

^ Boot BP (2015). “Comprehensive treatment of dementia with Lewy bodies”. Alzheimers Res Ther (Review). 7 (1): 45. doi: 10.1186 / s13195-015-0128-z. PMC 4448151. PMID 26029267.

^ “Circadin – Summary of Product Characteristics (SmPC) – (eMC)”. Electronic Medicines Compendium. 29 June 2007. Retrieved 1 March 2018.

^ Abdelgadir IS, Gordon MA, Akobeng AK (May 2018). “A systematic review and meta-analysis”. Arch. Dis. Child. 103 (12): 1155-1162. doi: 10.1136 / archdischild-2017-314181. PMID 29720494.

^ McCleery J, Cohen DA, Sharpley AL (November 2016). “Pharmacotherapies for sleep disturbances in dementia”. The Cochrane Database of Systematic Reviews. 11: CD009178. doi: 10.1002 / 14651858.cd009178.pub3. PMID 27851868.

^ a b Herxheimer A, Petrie KJ (2002). “Melatonin for the Prevention and Treatment of Jet Lag”. Cochrane Database Syst Rev (2): CD001520. doi: 10.1002 / 14651858.CD001520. PMID 12076414.

^ a b Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, Ruotsalainen JH (August 2014). “Pharmacological interventions for sleepiness and sleep disturbances caused by shift work”. The Cochrane Database of Systematic Reviews. 8 (8): CD009776. doi: 10.1002 / 14651858.CD009776.pub2. PMID 25113164.

^ Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S (2005). “The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis”. J Gen Intern Med. 20 (12): 1151–58. doi: 10.1111 / j.1525-1497.2005.0243.x. PMC 1490287. PMID 16423108.

^ Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G (February 2006). “Efficacy of exaturation for secondary sleep conditions and secondary restraints; BMJ. 332 (7538): 385–93. doi: 10.1136 / bmj.38731.532766.F6. PMC 1370968. PMID 16473858.

^ Lyseng-Williamson KA (2012). “Melatonin prolonged release in patients aged ≥55 years”. Drugs Aging. 29 (11): 911–23. doi: 10.1007 / s40266-012-0018-z. PMID 23044640.

^ Database of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Center for Reviews and Dissemination (UK); 1995. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature. 2014

^ Brent Bauer, M.D. “Melatonin side effects: What are the risks?”. Mayo Clinic. Retrieved 17 August 2011.

^ Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU (October 2001). “Melatonin treatment for age-related insomnia”. J. Clin. Endocrinol. Metab. 86 (10): 4727-30. doi: 10.1210 / jc.86.10.4727. PMID 11600532.

^ Morera AL, Henry M, de la Varga M (2001). “Seguridad en el uso de la melatonina” [Safety in melatonin use]. Actas Esp Psiquiatr (in Spanish). 29 (5): 334–37. PMID 11602091.

^ Terry PD, Villinger F, Bubenik GA, Sitaraman SV (January 2009). “Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research”. Inflamm. Bowel Dis. 15 (1): 134–40. doi: 10.1002 / ibd.20527. PMID 18626968.

^ Juszczak M, Michalska M (2006). “Wpływ melatoniny na syntezę i wydzielanie prolaktyny, hormonu luteinizującego (LH) i folikulotropowego (FSH)” [The effect of melatonin on prolactin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH); Postepy Hig Med Dosw (Online) (in Polish). 60: 431–38. PMID 16921343.

^ Srinivasan V, Spence WD, Pandi-Perumal SR, Zakharia R, Bhatnagar KP, Brzezinski A (December 2009). “Melatonin and human reproduction: shedding light on the darkness hormone”. Gynecol. Endocrinol. 25 (12): 779–85. doi: 10.3109 / 09513590903159649. PMID 19905996.

^ Shane-McWhorter L. Melatonin. Merck Manual Professional Version. October 2018. Accessed 22 April 2019.

^ Emet, M; Ozcan, H; Ozel, L; Yayla, M; Halici Z; Hacimuftuoglu, A (June 2016). “A Review of Melatonin, Its Receptors and Drugs.” The Eurasian Journal of Medicine. 48 (2): 135–41. doi: 10.5152 / eurasianjmed.2015.0267. PMC 4970552. PMID 27551178.

^ Ardura J, Gutierrez R, Andres J, Agapito T (2003). “Emergence and evolution of the circadian rhythm of melatonin in children”. Horm. Res. 59 (2): 66–72. doi: 10.1159 / 000068571. PMID 12589109.

^ Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM (1986). “Human melatonin production decreasing with age”. J. Pineal Res. 3 (4): 379–88. doi: 10.1111 / j.1600-079X.1986.tb00760.x. PMID 3783419.

^ Hagenauer MH, Perryman JI, Lee TM, Carskadon MA (June 2009). “Adolescent changes in the homeostatic and circadian regulation of sleep”. Developmental Neuroscience. 31 (4): 276–84. doi: 10.1159 / 000216538. PMC 2820578. PMID 19546564.

^ Tan DX, Chen LD, Poeggeler B, L Manchester C, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1993, 1, 57–60 https://docs.google.com/viewer?a=vpid=sitessrcid=ZGVmYXVsdGRvbWFpbnxkdW54aWFudGFufGd4OjVkMjA5NGZkMzFmYjRkOTU

^ Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LR (November 1994). “Melatonin – a highly potent endogenous radical in vitro”. Ann. N. Y. Acad. Sci. 738 (1): 419–20. Bibcode: 1994NYASA.738..419P. doi: 10.1111 / j.1749-6632.1994.tb21831.x. PMID 7832450.

^ a b Arnao MB, Hernández-Ruiz J (May 2006). “The physiological function of melatonin in plants”. Plant Signal Behav. 1 (3): 89–95. doi: 10.4161 / psb.1.3.2640. PMC 2635004. PMID 19521488.

^ Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F (1994). “Melatonin: a peroxyl radical scavenger more effective than vitamin E”. Life Sci. 55 (15): PL271–76. doi: 10.1016 / 0024-3205 (94) 00666-0. PMID 7934611.

^ a b c Sharafati-Chaleshtori R, Shirzad H, Rafieian-Kopaei M, Soltani A (2017). “Melatonin and human mitochondrial diseases”. Journal of Research in Medical Sciences. 22: 2. doi: 10.4103 / 1735-1995.199092. PMC 5361446. PMID 28400824.

^ a b c d e f g h Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E, Zlotos DP (September 2016). “Update on melatonin receptors: IUPHAR Review 20”. British Journal of Pharmacology. 173 (18): 2702–25. doi: 10.1111 / bph.13536. PMC 4995287. PMID 27314810. It makes it possible to increase the amount of reactive species, such as the vitamin C and vitamin E, under in vitro or in vivo conditions (Gitto et al., 2001; Sharma and Haldar, 2006; Ortiz et al., 2013).

^ a b c Reiter RJ, Rosales-Corral S, Tan DX, Jou MJ, Galano A, Xu B (November 2017). “Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas.” Cellular and Molecular Life Sciences. 74 (21): 3863–3881. doi: 10.1007 / s00018-017-2609-7. PMID 28864909. Melatonin is specifically targeted to the mitochondria where it seems to be the apox antioxidant …

^ a b c Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L (October 2016). “Melatonin as an antioxidant: under promises but over delivers”. Journal of Pineal Research. 61 (3): 253–278. doi: 10.1111 / jpi.12360. PMID 27500468. Mitochondria-targeted antioxidant.

^ a b c Manchester LC, Coto-Montes A, Boga JA, Andersen LP, Zhou Z, Galano A, Vriend J, Tan DX, Reiter RJ (November 2015). “Melatonin: an oxygen molecule that makes oxygen metabolically tolerable.” Journal of Pineal Research. 59 (4): 403–19. doi: 10.1111 / jpi.12267. PMID 26272235. It’s now known as the pineal gland [53] have been investigated [48, 55, 56]. It is not relegated solely to the pineal gland [57–59], it is not relegated.

^ a b c d e f Mayo JC, Sainz RM, González-Menéndez P, Hevia D, Cernuda-Cernuda R (November 2017). “Melatonin transport into mitochondria”. Cellular and Molecular Life Sciences. 74 (21): 3927–3940. doi: 10.1007 / s00018-017-2616-8. PMID 28828619.

^ Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ (July 2005). “A review of the multiple actions of the melatonin on the immune system.” Endocrine. 27 (2): 189–200. doi: 10.1385 / ENDO: 27: 2: 189. PMID 16217132.

Which Liquid Melatonin is beneficial and which are harmful? What fat is good for health?

^ Arushanian EB, Beĭer EV (2002). “[Immunotropic properties of pineal melatonin]”. Eksp Klin Farmakol (in Russian). 65 (5): 73–80. PMID 12596522.

^ Carrillo-Vico A, Reiter RJ, Lardone PJ, Herrera JL, Fernández-Montesinos R, Guerrero JM, Pozo D (May 2006). “The modulatory role of melatonin on immune responsiveness.” Curr Opin Investig Drugs. 7 (5): 423–31. PMID 16729718.

^ Maestroni GJ (March 2001). “The immunotherapeutic potential of melatonin”. Expert Opin Investig Drugs. 10 (3): 467–76. doi: 10.1517 / 13543784.10.3.467. PMID 11227046.

^ “MetaCyc serotonin and melatonin biosynthesis”.

^ a b c d e Tordjman, S; Chokron, S; Delorme, R; Charrier, A; Bellissant, E; Jaafari, N; Fougerou, C (April 2017). “Melatonin: Pharmacology, Functions and Therapeutic Benefits”. Current Neuropharmacology. 15 (3): 434–443. doi: 10.2174 / 1570159X14666161228122115. PMC 5405617. PMID 28503116.

^ Bochkov DV, Sysolyatin SV, Kalashnikov AI, Surmacheva IA (January 2012). “Shikimic acid: review and microbial sources”. Journal of Chemical Biology. 5 (1): 5–17. doi: 10.1007 / s12154-011-0064-8. PMC 3251648. PMID 22826715.

^ a b c Hardeland R (February 2015). “Melatonin in plants and other phototrophs: advances and gaps concerning the diversity of functions”. Journal of Experimental Botany. 66 (3): 627–46. doi: 10.1093 / jxb / eru386. PMID 25240067.

^ Tan, DX; Manchester, LC; Liu, X; Rosales-Corral, SA; Acuna-Castroviejo, D; Reiter, RJ (March 2013). “Mitochondria and chloroplasts as a hypothesis of the melatonin synthesis”. Journal of Pineal Research. 54 (2): 127–38. doi: 10.1111 / jpi.12026. PMID 23137057.

^ Roberts KM, Fitzpatrick PF (2013). “Mechanisms of tryptophan and tyrosine hydroxylase”. IUBMB Life. 65 (4): 350–57. doi: 10.1002 / iub.1144. PMC 4270200. PMID 23441081.

^ Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T (1992). “For human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis”. Biochemistry. 31 (8): 2229–38. doi: 10.1021 / bi00123a004. PMID 1540578.

^ a b Dewick PM (2002). Medicinal Natural Products. A Biosynthetic Approach (2nd ed.). Wiley. ISBN 978-0-471-49640-3.

^ Hickman AB, Klein DC, Dyda F (1999). “Melatonin biosynthesis: the structure of serotonin N-acetyltransferase at 2.5 A resolution suggests a catalytic mechanism”. Mol. Cell. 3 (1): 23–32. doi: 10.1016 / S1097-2765 (00) 80171-9. PMID 10024876.

^ Donohue SJ, Roseboom PH, Illnerova H, Weller JL, Klein DC (October 1993). “Human hydroxyindole-O-methyltransferase: presence of LINE-1 fragment in a cDNA clone and pineal mRNA.” DNA and Cell Biology. 12 (8): 715–27. doi: 10.1089 / dna.1993.12.715. PMID 8397829.

^ Nesbitt AD, Leschziner GD, Peatfield RC (September 2014). “Headache, drugs and sleep”. Cephalalgia (Review). 34 (10): 756–66. doi: 10.1177 / 0333102414542662. PMID 25053748.

^ Schomerus C, Korf HW (December 2005). “Mechanisms regulating melatonin synthesis in the mammalian pineal organ”. Annals of the New York Academy of Sciences. 1057 (1): 372–83. Bibcode: 2005NYASA1057..372S. doi: 10.1196 / annals.1356.028. PMID 16399907.

^ Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD (August 2001). “Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor.” J. Neurosci. 21 (16): 6405–12. doi: 10.1523 / JNEUROSCI.21-16-06405.2001. PMID 11487664.

^ “Recent News – Program of Computer Graphics”. www.graphics.cornell.edu.

^ Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro CM (May 2005). “Blocking the low-wavelength of light during the simulated shift work”. J. Clin. Endocrinol. Metab. 90 (5): 2755–61. doi: 10.1210 / jc.2004-2062. PMID 15713707.

^ Burkhart K, Phelps JR (26 December 2009). “Amber lenses to block blue light and improve sleep: a randomized trial.” Chronobiol Int. 26 (8): 1602-12. doi: 10.3109 / 07420520903523719. PMID 20030543.

^ “Melatonin receptors | G protein-coupled receptors | IUPHAR / BPS Guide to Pharmacology”. www.guidetopharmacology.org. Retrieved 7 April 2017.

^ Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC (October 2005). “Phase-dependent treatment of delayed sleep phase syndrome with melatonin”. Sleep. 28 (10): 1271–78. doi: 10.1093 / sleep / 10/28/1271. PMID 16295212.

^ Terman MR, Wirz-Justice A (2009). Chronotherapeutics for Affective Disorders: A Clinician’s Manual for Light and Wake Therapy. Basel: S Karger Pub. p. 71. ISBN 978-3-8055-9120-1.

^ “Melatonin”. www.drugbank.ca. Retrieved 29 January 2019.

^ Buscemi N, Vandermeer B, Pandya R, Hooton N, Tjosvold L, Hartling L, Baker G, Vohra S, Klassen T (November 2004). Melatonin for treatment of sleep disorders. Evidence Report / Technology Assessment (Summary). Agency for Healthcare Research and Quality (US). pp. 1–7. ISBN 9781587631702. PMC 4781368. PMID 15635761.

^ Filadelfi AM, Castrucci AM (May 1996). “Comparative aspects of the pineal / melatonin system of poikilothermic vertebrates.” J. Pineal Res. 20 (4): 175–86. doi: 10.1111 / j.1600-079X.1996.tb00256.x. PMID 8836950.

^ Sugden D, Davidson K, Hough KA, Teh MT (October 2004). “Melatonin, melatonin receptors and melanophores: a moving story”. Pigment Cell Res. 17 (5): 454–60. doi: 10.1111 / j.1600-0749.2004.00185.x. PMID 15357831.

^ Coates PM, Blackman MR, Cragg GM, Levine M, Moss J, White JD (2005). Encyclopedia of dietary supplements. New York, N.Y.: Marcel Dekker. pp. 457–66. ISBN 978-0-8247-5504-1.

^ McCord CP, Allen FP (January 1917). “Evidences associating pineal gland function with alterations in pigmentation”. J Exp Zool. 23 (1): 206–24. doi: 10.1002 / jez.1400230108.

^ Lerner AB, Case JD, Takahashi Y (July 1960). “Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands”. J. Biol. Chem. 235: 1992–97. PMID 14415935.

^ Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH (January 1975). “Daily rhythm in human urinary melatonin”. Science. 187 (4172): 169–71. Bibcode: 1975Sci … 187..169L. doi: 10.1126 / science.1167425. PMID 1167425.

^ Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC (May 1993). “Melatonin, hydroxyl radical-mediated oxidative damage and aging: a hypothesis.” J. Pineal Res. 14 (4): 151–68. doi: 10.1111 / j.1600-079X.1993.tb00498.x. PMID 8102180.

^ US Patent 5449683, Wurtman RJ, “Methods of inducing sleep using melatonin”, issued September 12, 1995, assigned to Massachusetts Institute of Technology

^ Arendt J (August 2005). “Melatonin: characteristics, concerns, and prospects”. J. Biol. Rhythms 20 (4): 291–303. doi: 10.1177 / 0748730405277492. PMID 16077149 for toxicity or undesirable effects in humans. In the recent past, the benefits of peace of mind.

^ Arendt J (October 2000). “Melatonin, circadian rhythms, and sleep”. N. Engl. J. Med. 343 (15): 1114–16. doi: 10.1056 / NEJM200010123431510. PMID 11027748.

^ Reiter RJ (May 1991). “Pineal melatonin: cell biology of physiological interactions”. Endocr. Rev. 12 (2): 151–80. doi: 10.1210 / edrv-12-2-151. PMID 1649044.

^ Richardson GS (2005). “The human circadian system in normal and disordered sleep.” J Clin Psychiatry. 66 Suppl 9: 3–9, quiz 42–3. PMID 16336035.

^ Perreau-Lenz S, Pévet P, Buijs RM, Kalsbeek A (January 2004). “The biological clock: the bodyguard of temporal homeostasis.” Chronobiol. Int. 21 (1): 1–25. doi: 10.1081 / CBI-120027984. PMID 15129821.

^ Lincoln GA, Andersson H, Loudon A (October 2003). “Clock genes in calendar cells as the basis of annual timekeeping in mammals – a unifying hypothesis.” J. Endocrinol. 179 (1): 1–13. doi: 10.1677 / joe.0.1790001. PMID 14529560.

^ a b Arendt J, Skene DJ (February 2005). “Melatonin as a chronobiotic”. Sleep Med Rev. 9 (1): 25–39. doi: 10.1016 / j.smrv.2004.05.002. PMID 15649736. Exogenous sleepiness during the biological daytime, and when it is time, it is possible to sleep (sleep, endogenous melatonin, core body temperature, cortisol) before (advance phase shift) or later (delay phase shift) times.

^ Chaturvedi CM (1984). “Effect of Melatonin on the Adrenl and the Gonad of Common Mynah Acridtheres tristis”. Australian Journal of Zoology. 32 (6): 803–09. doi: 10.1071 / ZO9840803.

^ Chen HJ (July 1981). “Spontaneous sensitivity: augmented sensitivity to melatonin inhibition”. Neuroendocrinology. 33 (1): 43–46. doi: 10.1159 / 000123198. PMID 7254478.

Melatonin Depression alternating menu

^ Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ (1 January 2009). “Phytomelatonin: a review”. Journal of Experimental Botany. 60 (1): 57–69. doi: 10.1093 / jxb / ern284. PMID 19033551.

^ a b c Tan DX, Hardeland R, Manchester LC, Korkmaz A, Ma S, Rosales-Corral S, Reiter RJ (January 2012). “Functional roles of melatonin plants and plants and nutritional and agricultural science”. Journal of Experimental Botany. 63 (2): 577–97. doi: 10.1093 / jxb / err256. PMID 22016420.

^ Bonnefont-Rousselot D, Collin F (November 2010). “Melatonin: antioxidant disease and aging”. Toxicology. 278 (1): 55–67. doi: 10.1016 / j.tox.2010.04.008. PMID 20417677.

^ Reiter RJ, Manchester LC, Tan DX (September 2005). “Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood.” Nutrition. 21 (9): 920–24. doi: 10.1016 / j.nut 2005.02.005. PMID 15979282.

^ Reiter RJ, Tan DX, Zhou Z, Cruz MH, Fuentes-Broto L, Galano A (April 2015). “Phytomelatonin: assisting plants to survive and thrive”. Molecules. 20 (4): 7396–437. doi: 10.3390 / molecules20047396. PMC 6272735. PMID 25911967.

^ Arnao MB, Hernández-Ruiz J (September 2015). “Functions of melatonin in plants: a review”. Journal of Pineal Research. 59 (2): 133–50. doi: 10.1111 / jpi.12253. PMID 26094813.

^ Buscemi N, Vandermeer B, Pandya R, Hooton N, Tjosvold L, Hartling L, Baker G, Vohra S, Klassen T (November 2004). “Melatonin for treatment of sleep disorders” (PDF). Evidence Report / Technology Assessment No. 108. (Prepared by the University of Alberta Evidence-based Practice Center, under Contract No. 290-02-0023.) AHRQ Publication No. 05-E002-2. Rockville, MD: Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services. Retrieved 5 June 2013.

^ Guardiola-Lemaître B (December 1997). “Toxicology of melatonin”. Journal of Biological Rhythms. 12 (6): 697–706. doi: 10.1177 / 074873049701200627. PMID 9406047.

^ Burkhardt S, Tan DX, Manchester LC, Hardeland R, Reiter RJ (October 2001). “Detection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries (Prunus cerasus)”. J. Agric. Food Chem. 49 (10): 4898–902. doi: 10.1021 / jf010321. PMID 11600041.

^ González-Flores D, Velardo B, Garrido M, González-Gómez D, Lozano M, Ayuso MC, Barriga C, Paredes SD, Rodríguez AB (2011). “Prunus salicina Lindl. Cv. Crimson Globe)” increases the urinary 6-sulfatoxymelatonin and total toxic levels of young people: Nutritional and functional characterization of their content. ” Journal of Food and Nutrition Research. 50 (4): 229–36.

^ Lamont KT, Somers S, Lacerda L, Opie LH, Lecour S (May 2011). “Is it a red wine SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection.” Journal of Pineal Research. 50 (4): 374–80. doi: 10.1111 / j.1600-079X.2010.00853.x. PMID 21342247.

^ Hattori A, Migitaka H, ​​Iigo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJ (March 1995). Melatonin receptors in vertebrates “. Biochem. Mol. Biol. Int. 35 (3): 627–34. PMID 7773197.

^ Sae-Teaw M, Johns J, Johns NP, Subongkot S (October 2012). “Healthy male volunteers’ serum melatonin levels and antioxidant levels after consumption. J. Pineal Res. 55 (1): 58–64. doi: 10.1111 / jpi.12025. PMID 23137025.

^ Catherine Saint Louis (14 May 2011). “Dessert, Laid-Back and Legal”. New York Times.

^ Rodriguez RR (13 January 2010). “Warning Letter”. Inspections, Compliance, Enforcement, and Criminal Investigations. U.S. Food and Drug Administration. Archived from the original on 12 January 2017.CS1 maint: BOT: original-url status unknown (link)

^ Bebida Beverage Company U.S. Food and Drug Administration 4 March 2015 (Accessed 8 December 2017)

^ “Melatonin”. Drugs.com. Retrieved 17 August 2011.

^ Loria, Kevin. “Does Melatonin Really Help You Sleep?”. Consumer Reports. Retrieved 16 March 2019.

^ Miroddi M, Bruno R, Galletti F, Calapai F, Navarra M, Gangemi S, Calapai G (March 2015). “Clinical pharmacology of melatonin in the treatment of tinnitus: a review”. European Journal of Clinical Pharmacology. 71 (3): 263–70. doi: 10.1007 / s00228-015-1805-3. PMID 25597877.

^ Peres MF, Masruha MR, Zukerman E, Moreira-Filho CA, Cavalheiro EA (April 2006). “Potential therapeutic use of melatonin in migraine and other headache disorders”. Expert Opinion on Investigational Drugs. 15 (4): 367–75. doi: 10.1517 / 13543784.15.4.367. PMID 16548786.

^ Evars S, Goadsby P (2005). “Review: Hypnic headache” (PDF). Practical Neurology. 5 (3): 144–49. doi: 10.1111 / j.1474-7766.2005.00301.x. Retrieved 12 January 2018.

^ National Cancer Institute (May 2013). “Topics in complementary and alternative therapies (PDQ)”. National Cancer Institute, National Institutes of Health. PMID 26389506. Retrieved 5 June 2013.

^ Mills E, Wu P, Seely D, Guyatt G (November 2005). “Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis”. J. Pineal Res. 39 (4): 360–66. doi: 10.1111 / j.1600-079X.2005.00258.x. PMID 16207291.

^ Meltz ML, Reiter RJ, Herman TS, Kumar KS (March 1999). “Melatonin and protection from whole-body irradiation: survival studies in mice”. Mutation Research. 425 (1): 21–7. doi: 10.1016 / S0027-5107 (98) 00246-2. PMID 10082913.

^ Reiter RJ, Herman TS, Meltz ML (December 1996). “Melatonin and radioprotection of genetic damage: in vivo / in vitro studies with human volunteers.” Mutation Research. 371 (3–4): 221–8. doi: 10.1016 / S0165-1218 (96) 90110-X. PMID 9008723.

^ Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, Marjoribanks J (March 2016). “Dietary supplements for dysmenorrhoea.” The Cochrane Database of Systematic Reviews. 3 (3): CD002124. doi: 10.1002 / 14651858.cd002124.pub2. PMID 27000311.

^ Reiter RJ, Herman TS, Meltz ML (February 1998). “Melatonin reduces gamma radiation-induced lymphocytes. Mutation Research. 397 (2): 203–8. doi: 10.1016 / S0027-5107 (97) 00211-X. PMID 9541644.

^ Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (January 2007). “One molecule, many derivatives: a interaction between the melatonin with a reactive oxygen and nitrogen species?”. Journal of Pineal Research. 42 (1): 28–42. doi: 10.1111 / j.1600-079X.2006.00407.x. PMID 17198536.

^ Shirazi A, Ghobadi G, Ghazi-Khansari M (July 2007). “A radiobiological review on melatonin: a novel radioprotector.” Journal of Radiation Research. 48 (4): 263–72. Bibcode: 2007JRadR..48..263S. doi: 10.1269 / jrr.06070. PMID 17641465.

^ Brigo F, Igwe SC, Del Felice A (August 2016). “Melatonin as add-on treatment for epilepsy”. The Cochrane Database of Systematic Reviews (8): CD006967. doi: 10.1002 / 14651858.CD006967.pub4. PMID 27513702.

^ Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, Marjoribanks J (March 2016). “Dietary supplements for dysmenorrhoea.” The Cochrane Database of Systematic Reviews. 3: CD002124. doi: 10.1002 / 14651858.CD002124.pub2. PMID 27000311.

^ Siddiqi N, Harrison JK, Clegg A, Teale EA, Young J, Taylor J, Simpkins SA (March 2016). “Interventions for preventing delirium in hospitalized non-ICU patients”. The Cochrane Database of Systematic Reviews. 3: CD005563. doi: 10.1002 / 14651858.CD005563.pub3. PMID 26967259.

^ Kandil TS, Mousa AA, El-Gendy AA, Abbas AM (January 2010). “The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease”. BMC Gastroenterology. 10: 7. doi: 10.1186 / 1471-230X-10-7. PMC 2821302. PMID 20082715.

^ Braam W, Smits MG, Didden R, Korzilius H, Van Geijlswijk IM, Curfs LM (May 2009). “Meta-analysis”. Dev Med Child Neurol (Meta-analysis). 51 (5): 340–49. doi: 10.1111 / j.1469-8749.2008.03244.x. PMID 19379289.

^ a b Rossignol DA, Frye RE (April 2011). “Melatonin in autism review: a systematic review and meta-analysis”. Dev Med Child Neurol (Meta-analysis). 53 (9): 783–92. doi: 10.1111 / j.1469-8749.2011.03980.x. PMID 21518346.

^ Veatch OJ, Pendergast JS, Allen MJ, Leu RM, Johnson CH, Elsea SH, Malow BA (January 2015). “The pathway and comorbid sleep onset delay” J Autism Dev Disord. 45 (1): 100–10. doi: 10.1007 / s10803-014-2197-4. PMC 4289108. PMID 25059483.

^ “Melatonin in children with asperger disorder”. Truthly. Retrieved 15 February 2015.

^ Giannotti F, Cortesi F, Cerquiglini A, Bernabei P (August 2006). “An open-label study of controlled-release melatonin in children with autism”. J Autism Dev Disord. 36 (6): 741–52. doi: 10.1007 / s10803-006-0116-z. PMID 16897403.

^ Bendz LM, Scates AC (January 2010). “Melatonin treatment for insomnia in pediatric patients with attention-deficit / hyperactivity disorder”. Ann Pharmacother. 44 (1): 185–91. doi: 10.1345 / aph.1M365. PMID 20028959.

^ Hansen MV, Halladin NL, Rosenberg J, Gögenur I, Møller AM (2015). “Melatonin for pre- and postoperative anxiety in adults”. Cochrane Database Syst Rev (4): CD009861. doi: 10.1002 / 14651858.CD009861.pub2. PMID 25856551.

^ Lewis, Alan (1999). Melatonin and the Biological Clock. McGraw-Hill. p. 23. ISBN 978-0-87983-734-1.

^ Valdés-Tovar, M; Estrada-Reyes, R; Solís-Chagoyán, H; Argueta, J; Dorantes-Barrón, AM; Quero-Chávez, D; Cruz-Garduño, R; Cercós, MG; Trueta, C; Oikawa-Sala, J; Dubocovich, ML; Benítez-King, G (7 March 2018). “Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression.” British Journal of Pharmacology. 175 (16): 3200–3208. doi: 10.1111 / bph.14197. PMC 6057892. PMID 29512136.